Terms: = Breast cancer AND RARA, RAR, 5914, ENSG00000131759, NR1B1 AND Clinical Outcome
3 results:
1. HiFreSP: A novel high-frequency sub-pathway mining approach to identify robust prognostic gene signatures.
Li M; Zhao J; Li X; Chen Y; Feng C; Qian F; Liu Y; Zhang J; He J; Ai B; Ning Z; Liu W; Bai X; Han X; Wu Z; Xu X; Tang Z; Pan Q; Xu L; Li C; Wang Q; Li E
Brief Bioinform; 2020 Jul; 21(4):1411-1424. PubMed ID: 31350847
[TBL] [Abstract] [Full Text] [Related]
2. CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid.
Liu RZ; Garcia E; Glubrecht DD; Poon HY; Mackey JR; Godbout R
Mol Cancer; 2015 Jul; 14():129. PubMed ID: 26142905
[TBL] [Abstract] [Full Text] [Related]
3. Expression levels of HER2/neu and those of collocated genes at 17q12-21, in breast cancer.
Glynn RW; Miller N; Mahon S; Kerin MJ
Oncol Rep; 2012 Jul; 28(1):365-9. PubMed ID: 22552811
[TBL] [Abstract] [Full Text] [Related]
